欢迎来到 CSNpharm! 产品仅用于科研!
首页 Compound Arrays 促销产品
400-920-2911 sales@csnpharm.cn    

ALK

ALK

货号 产品名 CAS号 信息
CSN22607 TP0427736 HCl 2459963-17-6 TP0427736 HCl is the HCl form of TP0427736 which is an inhibitor of ALK5 with IC50 of 2.72 nM and can reduce TGF-β induced growth.
CSN22508 SM 16 614749-78-9 SM 16 is an an ATP-competitive ALK5/ALK4 inhibitor with IC50 value between 160 and 620 nM for inhibition of TGF-β1-induced Smad2/3 phosphorylation in cell study.
CSN16207 LDK378 2HCl 1380575-43-8 LDK378 2HCl is a selective ALK inhibitor with an IC50 of 0.2 nM, and also inhibits InsR, IGF-1R, STK22D, FLT3 and FGFR2 with IC50 values of 7 nM, 8 nM, 23 nM, 60 nM and 260 nM.
CSN21367 JH-VIII-157-02 1639422-97-1 JH-VIII-157-02 is a structural analogue of alectinib, acts as an ALK inhibitor, and shows an IC50 of 2 nM for echinoderm microtubule-associated protein-like 4-ALK (EML4-ALK) G1202R in cells.
CSN17746 HG-14-10-04 1356962-34-9 HG-14-10-04 is a potent and specific ALK inhibitor with IC50 of 20 nM.
CSN18668 X-376 1365267-27-1 Ensartinib is a potent inhibitor ofALK, which is used to treat non-small-cell lung cancer.
CSN22549 Ensartinib 1370651-20-9 Ensartinib is a novel, potent anaplastic lymphoma kinase (ALK) small molecule tyrosine kinase inhibitor (TKI) with additional activity against MET, ABL, Axl, EPHA2, LTK, ROS1 and SLK. ALK autophosphorylation is significantly diminished by X-396, albeit at higher concentrations required to block autophosphorylation of the wild-type fusion.
CSN13803 Crizotinib HCl 1415560-69-8 Crizotinib HCl is a potent inhibitor of c-Met and ALK with IC50 of 11 nM and 24 nM, respectivley.
CSN15842 CH5424802 HCl 1256589-74-8 CH5424802 HCl is a potent ALK inhibitor with IC50 of 1.9 nM, sensitive to L1196M mutation.
CSN19158 CEP-28122 Mesylate 1431697-88-9 CEP-28122 mesylate is a highly potent and selective orally active ALK inhibitor with IC50 of 1.9 ± 0.5 nM in an enzyme-based TRF assay.
CSN16925 CEP-28122 1022958-60-6 CEP-28122 is a highly potent and selective orally active ALK inhibitor with IC50 of 1.9 ± 0.5 nM in an enzyme-based TRF assay.
CSN22546 Belizatinib 1357920-84-3 Belizatinib is a selective ALK inhibitor with IC50 value of 0.7nM, as well as shows potency against TRK A, B, and C with IC50 values<3nM.
CSN15910 AZD3463 1356962-20-3 AZD3463 is an orally bioavailable ALK inhibitor with Ki of 0.75 nM, which also inhibits IGF1R with equivalent potency.
CSN19724 ALK Inhibitor C29 2093414-37-8 ALK inhibitor C29 shows promising anti-ALK activities in enzymatic- and cell-based assays, while in vivo H3122 xenograft model study showed that it effectively suppressed ALK-driven tumor growth.
CSN18423 ALK Inhibitor 2 761438-38-4 ALK inhibitor 2 is a selective inhibitor for the ALK kinase.
CSN18422 ALK Inhibitor 1 761436-81-1 ALK inhibitor 1 is a selective inhibitor for the ALK kinase.
<< PREV 1 NEXT >>